Fusion Gene Studies
in Kim Lab

FusionBase FusionGDB FusionGDB2 FusionPDB FusionNeoAntigen FusionAI FusionNW FGviewer Publication Contact
FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:FLNA-ARID5B (FusionGDB2 ID:HG2316TG84159)

Fusion Gene Summary for FLNA-ARID5B

check button Fusion gene summary
Fusion gene informationFusion gene name: FLNA-ARID5B
Fusion gene ID: hg2316tg84159
HgeneTgene
Gene symbol

FLNA

ARID5B

Gene ID

2316

84159

Gene namefilamin AAT-rich interaction domain 5B
SynonymsABP-280|ABPX|CSBS|CVD1|FGS2|FLN|FLN-A|FLN1|FMD|MNS|NHBP|OPD|OPD1|OPD2|XLVD|XMVDDESRT|MRF-2|MRF2
Cytomap('FLNA')('ARID5B')

Xq28

10q21.2

Type of geneprotein-codingprotein-coding
Descriptionfilamin-Aactin binding protein 280alpha-filaminendothelial actin-binding proteinepididymis secretory sperm binding proteinfilamin A, alphafilamin-1non-muscle filaminAT-rich interactive domain-containing protein 5BARID domain-containing protein 5BAT-rich interactive domain 5B (MRF1-like)MRF1-like proteinmodulator recognition factor 2 (MRF2)
Modification date2020031320200313
UniProtAcc..
Ensembl transtripts involved in fusion geneENST00000344736, ENST00000360319, 
ENST00000369850, ENST00000369856, 
ENST00000422373, ENST00000498491, 
Fusion gene scores* DoF score24 X 29 X 9=626413 X 12 X 2=312
# samples 3413
** MAII scorelog2(34/6264*10)=-4.20347756115334
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(13/312*10)=-1.26303440583379
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: FLNA [Title/Abstract] AND ARID5B [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointFLNA(153590692)-ARID5B(63852983), # samples:1
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneFLNA

GO:0016479

negative regulation of transcription by RNA polymerase I

22307607

HgeneFLNA

GO:0030334

regulation of cell migration

16291724

HgeneFLNA

GO:0031532

actin cytoskeleton reorganization

10051605

HgeneFLNA

GO:0034394

protein localization to cell surface

18322202

HgeneFLNA

GO:0043113

receptor clustering

10692483

HgeneFLNA

GO:0043433

negative regulation of DNA-binding transcription factor activity

15684392

HgeneFLNA

GO:0044319

wound healing, spreading of cells

16291724

HgeneFLNA

GO:0045184

establishment of protein localization

18322202

HgeneFLNA

GO:0051764

actin crosslink formation

10051605

HgeneFLNA

GO:0072659

protein localization to plasma membrane

24951510

HgeneFLNA

GO:0090307

mitotic spindle assembly

18548008

HgeneFLNA

GO:1901381

positive regulation of potassium ion transmembrane transport

24951510

TgeneARID5B

GO:0000122

negative regulation of transcription by RNA polymerase II

8649988

TgeneARID5B

GO:0051091

positive regulation of DNA-binding transcription factor activity

21532585



check button Fusion gene information
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand


Top

Fusion Gene ORF analysis for FLNA-ARID5B

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score

Top

Fusion Genomic Features for FLNA-ARID5B


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)


Top

Fusion Protein Features for FLNA-ARID5B


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:153590692/:63852983)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
..
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

Fusion Gene Sequence for FLNA-ARID5B


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

Top

Fusion Gene PPI Analysis for FLNA-ARID5B


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for FLNA-ARID5B


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status

Top

Related Diseases for FLNA-ARID5B


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneFLNAC1848213Periventricular Heterotopia, X-Linked9CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneFLNAC0025237Melnick-Needles Syndrome7CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
HgeneFLNAC4707243Familial thoracic aortic aneurysm and aortic dissection7CLINGEN;GENOMICS_ENGLAND
HgeneFLNAC0265251Oto-Palato-digital syndrome type 16CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneFLNAC1844696OTOPALATODIGITAL SYNDROME, TYPE II6CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneFLNAC0265293Frontometaphyseal dysplasia5CTD_human;GENOMICS_ENGLAND;ORPHANET
HgeneFLNAC1846129Terminal Osseous Dysplasia and Pigmentary Defects4CTD_human;GENOMICS_ENGLAND;ORPHANET
HgeneFLNAC4281559FRONTOMETAPHYSEAL DYSPLASIA 14GENOMICS_ENGLAND;UNIPROT
HgeneFLNAC0262436Cardiac valvular dysplasia, X-linked2CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneFLNAC0543888Epileptic encephalopathy2GENOMICS_ENGLAND
HgeneFLNAC1845902FG SYNDROME 22CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneFLNAC1868720Periventricular Nodular Heterotopia2CTD_human
HgeneFLNAC2746068Congenital idiopathic intestinal pseudoobstruction2CTD_human;GENOMICS_ENGLAND
HgeneFLNAC4551969Bilateral Periventricular Nodular Heterotopia2CTD_human
HgeneFLNAC0006142Malignant neoplasm of breast1CTD_human
HgeneFLNAC0010701Phyllodes Tumor1CTD_human
HgeneFLNAC0013366Dyschondroplasias1CTD_human
HgeneFLNAC0014544Epilepsy1CTD_human
HgeneFLNAC0021847Intestinal Pseudo-Obstruction1ORPHANET
HgeneFLNAC0023893Liver Cirrhosis, Experimental1CTD_human
HgeneFLNAC0026760Multiple Epiphyseal Dysplasia1CTD_human
HgeneFLNAC0029422Osteochondrodysplasias1CTD_human
HgeneFLNAC0036391Schwartz-Jampel Syndrome1CTD_human
HgeneFLNAC0038015Spondyloepiphyseal Dysplasia1CTD_human
HgeneFLNAC0086237Epilepsy, Cryptogenic1CTD_human
HgeneFLNAC0220769FG syndrome1CTD_human
HgeneFLNAC0236018Aura1CTD_human
HgeneFLNAC0268341Ehlers-Danlos syndrome type 51ORPHANET
HgeneFLNAC0432272Van Buchem disease1CTD_human
HgeneFLNAC0600066Malignant Cystosarcoma Phyllodes1CTD_human
HgeneFLNAC0678222Breast Carcinoma1CTD_human
HgeneFLNAC0751111Awakening Epilepsy1CTD_human
HgeneFLNAC1257931Mammary Neoplasms, Human1CTD_human
HgeneFLNAC1458155Mammary Neoplasms1CTD_human
HgeneFLNAC1845235Heterotopia, Periventricular, Ehlers-Danlos Variant1CTD_human
HgeneFLNAC1845546FG SYNDROME 4 (disorder)1CTD_human
HgeneFLNAC1845567FG SYNDROME 31CTD_human
HgeneFLNAC1855733Neuronal intestinal pseudoobstruction1ORPHANET
HgeneFLNAC2751260Macrothrombocytopenia1GENOMICS_ENGLAND
HgeneFLNAC3541456Spondyloepiphyseal Dysplasia Tarda, X-Linked1CTD_human
HgeneFLNAC4551479Schwartz-Jampel Syndrome, Type 11CTD_human
HgeneFLNAC4704874Mammary Carcinoma, Human1CTD_human
TgeneC0003873Rheumatoid Arthritis2CTD_human
TgeneC0023452Childhood Acute Lymphoblastic Leukemia2CTD_human
TgeneC0023453L2 Acute Lymphoblastic Leukemia2CTD_human
TgeneC1961102Precursor Cell Lymphoblastic Leukemia Lymphoma2CTD_human
TgeneC0010606Adenoid Cystic Carcinoma1CTD_human
TgeneC0013221Drug toxicity1CTD_human
TgeneC0018213Graves Disease1CTD_human
TgeneC0041755Adverse reaction to drug1CTD_human